Related Experiment Video
Updated: May 2, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
9.2K
Association of IL-4 promoter polymorphisms with asthma: a meta-analysis
1School of Basic Medical Science, Changsha Medical University, Changsha, China.
Genetics and Molecular Research : GMR
|March 18, 2014
Summary
Interleukin-4 (IL-4) promoter polymorphisms C-33T and C-589T are linked to asthma susceptibility, particularly in European adults. Further global research is needed to confirm these genetic associations with asthma risk.
Area of Science:
- Genetics
- Immunology
- Respiratory Medicine
Background:
- Asthma is a complex respiratory disease with a significant genetic component.
- Interleukin-4 (IL-4) plays a crucial role in allergic inflammation and asthma pathogenesis.
- Polymorphisms in the IL-4 gene promoter may influence IL-4 expression and asthma susceptibility.
Purpose of the Study:
- To precisely assess the correlation between specific interleukin-4 (IL-4) promoter polymorphisms and asthma susceptibility.
- To investigate the association of IL-4 promoter polymorphisms (C-33T, C-589T, G-1098T) with asthma risk.
Main Methods:
- A meta-analysis was conducted using data from MEDLINE up to September 2011.
- Association studies focused on IL-4 promoter C-33T, C-589T, and G-1098T polymorphisms and asthma.
- Subgroup analyses were performed based on population (European) and asthma status (adults).
Main Results:
- The IL-4 promoter polymorphisms C-33T and C-589T showed a significant association with asthma.
- These significant associations were primarily observed within the European population.
- The TT+CT genotype of these polymorphisms was significantly linked to asthma in adults.
Conclusions:
- IL-4 promoter polymorphisms C-589T and C-33T are associated with asthma susceptibility in Europeans.
- The findings suggest a potential genetic link between IL-4 promoter variations and asthma in specific populations.
- Larger, worldwide studies are necessary to confirm these correlations and elucidate the global impact of IL-4 promoter polymorphisms on asthma risk.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
9.6K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.0K
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49